Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.

J Exp Clin Cancer Res · 2017 · PMC5591524 · PMID 28886730

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

(B) Mascot database search based on MALDI-TOF-MS/MS matched to Annexin A2 with highly significant scores.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.